Friedl-Naderer Johanna 4
4 · Dyne Therapeutics, Inc. · Filed Sep 3, 2024
Insider Transaction Report
Form 4
Friedl-Naderer Johanna
Chief Commercial Officer
Transactions
- Award
Common Stock
2024-09-03+58,400→ 58,400 total - Award
Stock Option (Right to Buy)
2024-09-03+185,300→ 185,300 totalExercise: $31.94Exp: 2034-09-02→ Common Stock (185,300 underlying)
Footnotes (2)
- [F1]Consists of shares of Common Stock issuable under 58,400 restricted stock units ("RSU"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on September 3, 2025.
- [F2]This option was granted on September 3, 2024. The shares underlying the option are scheduled to vest over four years, with 25% of the shares vesting on September 3, 2025, and the remainder vesting in equal quarterly installments thereafter, subject to continuous service.